Larimar Therapeutics (LRMR) Gross Profit: 2012-2019
Historic Gross Profit for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2019 value amounting to -$1.8 million.
- Larimar Therapeutics' Gross Profit rose 39.80% to -$301,000 in Q1 2020 from the same period last year, while for Mar 2020 it was -$1.6 million, marking a year-over-year increase of 19.23%. This contributed to the annual value of -$1.8 million for FY2019, which is 6.95% up from last year.
- Larimar Therapeutics' Gross Profit amounted to -$1.8 million in FY2019, which was up 6.95% from -$1.9 million recorded in FY2018.
- Larimar Therapeutics' Gross Profit's 5-year high stood at -$165,000 during FY2017, with a 5-year trough of -$1.9 million in FY2018.
- Moreover, its 3-year median value for Gross Profit was -$1.8 million (2019), whereas its average is -$1.3 million.
- Per our database at Business Quant, Larimar Therapeutics' Gross Profit spiked by 68.81% in 2017 and then plummeted by 1,050.30% in 2018.
- Yearly analysis of 5 years shows Larimar Therapeutics' Gross Profit stood at -$806,000 in 2015, then soared by 34.37% to -$529,000 in 2016, then soared by 68.81% to -$165,000 in 2017, then plummeted by 1,050.30% to -$1.9 million in 2018, then increased by 6.95% to -$1.8 million in 2019.